These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 7250073)

  • 1. The effect of nomifensine on prolactin secretion in patients with suspected pituitary microadenoma.
    Jeske W; Stopińska U
    Endokrynol Pol; 1981; 32(1):17-24. PubMed ID: 7250073
    [No Abstract]   [Full Text] [Related]  

  • 2. Nomifensine: diagnostic test in hyperprolactinemic states.
    Müller EE; Genazzani AR; Murru S
    J Clin Endocrinol Metab; 1978 Dec; 47(6):1352-7. PubMed ID: 263356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the responses in the nomifensine test with hyperprolactinemia due to prolactin-secreting pituitary tumors and nonprolactin-secreting hypothalamic tumors.
    Kamoi K; Tchuchida I; Sato H; Tanaka R; Ishiguro T; Kaneko K; Iwasaki Y; Shibata A
    J Clin Endocrinol Metab; 1981 Dec; 53(6):1285-7. PubMed ID: 7298805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Failure of nomifensine administration to discriminate between tumorous and nontumorous hyperprolactinemia.
    Ferrari C; Crosignani PG; Caldara R; Picciotti MC; Malinverni A; Barattini B; Rampini P; Telloli P
    J Clin Endocrinol Metab; 1980 Jan; 50(1):23-6. PubMed ID: 7188615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Approach to the diagnosis of hyperprolactinemic states: the nomifensine and domperidone tests.
    Molinatti GM; Camanni F; Cocchi D; De Leo V; Genazzni AR; Massara F; Muller EE
    Panminerva Med; 1981; 23(1):5-10. PubMed ID: 7290727
    [No Abstract]   [Full Text] [Related]  

  • 6. [Indirect dopamine agonists and direct dopamine antagonists in the diagnosis of hyperprolactinemia].
    De Leo V; Massafra C; La Marca S; De Leo M; Venturi C; Urbani TM; Genazzani AR
    Boll Soc Ital Biol Sper; 1982 Aug; 58(16):1025-31. PubMed ID: 7138672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Some critical considerations on the use of the nomifensine test in the hyperprolactinaemic syndrome.
    D'Agata R; Aliffi A; Vicari E; Volpicelli D; Mongioì A; Gulizia S
    Horm Res; 1981; 14(3):148-54. PubMed ID: 7286887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tests of prolactin secretion in the diagnosis of hyperprolactinemic states: nomifensine and domperidone.
    Massara F; Genazzani AR; Camanni F; De Leo V; Molinatti GM; Müller EE
    Fertil Steril; 1981 Feb; 35(2):149-54. PubMed ID: 7202740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nomifensine in the diagnosis of hyperprolactinemia.
    Gullo D; Carmina E; Mogavero G; Perino A; Venezia R
    Acta Eur Fertil; 1981 Dec; 12(4):299-306. PubMed ID: 7342611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Progress in the hormonal detection of pituitary prolactin adenoma].
    De Gennes JL; Turpin G; Heshmati HM; Carayon A
    Ann Med Interne (Paris); 1982; 133(1):12-6. PubMed ID: 7065584
    [No Abstract]   [Full Text] [Related]  

  • 11. Benserazide and nomifensine in the diagnosis of prolactin-secreting pituitary adenomas.
    Pontiroli AE; Loda G; Roggia A; Scagliola P; Falsetti L
    Acta Endocrinol (Copenh); 1982 Oct; 101(2):171-9. PubMed ID: 7136447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of two inhibitory tests (nomifensine and L-dopa + carbidopa) for the diagnosis of hyperprolactinaemic states.
    Moriondo P; Travaglini P; Nissim M; Faglia G
    Clin Endocrinol (Oxf); 1980 Dec; 13(6):525-33. PubMed ID: 7226570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Agreement of prolactin response to cimetidine and nomifensine in patients with prolactin-secreting tumors and idiopathic hyperprolactinemia.
    Iodice M; Lombardi G; Tommaselli A; Rossi R; Annunziato L; Minozzi M
    Neuroendocrinology; 1982 Nov; 35(5):333-5. PubMed ID: 7145025
    [No Abstract]   [Full Text] [Related]  

  • 14. Nomifensine-induced pregnancy in a hyperprolactinemic woman.
    Genazzani AR; De Leo V; Camanni F; Müller EE
    J Endocrinol Invest; 1982; 5(2):129-30. PubMed ID: 7096920
    [No Abstract]   [Full Text] [Related]  

  • 15. Prolactin responsiveness to nomifensine in patients with hyperprolactinemia of tumorous or uncertain etiology.
    Camanni F; Genazzani AR; Massara F; de Leo V; Molinatti GM; Müller EE
    J Clin Endocrinol Metab; 1980 Sep; 51(3):650-3. PubMed ID: 7410539
    [No Abstract]   [Full Text] [Related]  

  • 16. Biochemical diagnosis of prolactinoma.
    Müller EE; Genazzani A; Camanni F; Massara F; Molinatti GM; Cocchi D
    Lancet; 1979 Aug; 2(8136):257. PubMed ID: 89375
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of two indirectly acting dopamine agonists on prolactin secretion in normo- and hyperprolactinemic subjects: comparison with the effect of nomifensine.
    Camanni F; Genazzani AR; de Leo V; Molinatti GM; Campagnoli C; Cocchi D; Müller EE
    Neuroendocrinology; 1981 Nov; 33(5):300-5. PubMed ID: 7301051
    [No Abstract]   [Full Text] [Related]  

  • 18. [The metoclopramide and nomifensine tests in the diagnosis of prolactinomas].
    Aguirre Sánchez-Covisa M; Ruiz-Valdepeñas MP; Larrodera L; Jaunsolo MA; Hawkins FG
    Rev Clin Esp; 1986 Mar; 178(4):172-6. PubMed ID: 3715120
    [No Abstract]   [Full Text] [Related]  

  • 19. Prolactin production by pituitary adenomas.
    Horvath E; Kovacs K; Ezrin C
    JAMA; 1976 Oct; 236(15):1692-3. PubMed ID: 989507
    [No Abstract]   [Full Text] [Related]  

  • 20. [Prolactin-secreting pituitary gland adenoma. Present-day possibilities of diagnosis and treatment].
    Basso A; Guitelman A; Amezua L; Molocznik I; Mancini A; Montez M
    Neurochirurgie; 1975; 21(2):111-20. PubMed ID: 1105224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.